Foghorn Therapeutics (FHTX) Other Operating Expenses (2024 - 2025)
Foghorn Therapeutics' (FHTX) quarterly Other Operating Expenses came in at $4.3 million in Q4 2025, up 78.57% quarter-over-quarter from $2.4 million in Q2 2024.
Foghorn Therapeutics (FHTX) Other Operating Expenses (2024 - 2025) Analysis & Trends
Foghorn Therapeutics' Other Operating Expenses history runs 2 years deep, the most recent figure standing at $4.3 million for Q4 2025.
- On a quarterly basis, Other Operating Expenses changed N/A year-over-year to $4.3 million in Q4 2025; TTM through Mar 2026 was $4.3 million, a 78.57% increase from a year earlier, with the FY2025 full-year figure at $4.3 million, up 78.57% from the prior year.
- Other Operating Expenses grew to $4.3 million in Q4 2025 per FHTX's latest filing, from $2.4 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $4.3 million in Q4 2025 and bottomed at $2.4 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Foghorn Therapeutics | 352.57 Mn | 263.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.28 Mn |
| Jun 30, 2024 | 2.40 Mn |